Article

B + L appoints Grant for surgical business

Bausch + Lomb has named Robert E. Grant chief executive officer and president of its global surgical business, effective Aug. 1.

Rochester, NY-Bausch + Lomb has named Robert E. Grant chief executive officer (CEO) and president of its global surgical business, effective Aug. 1.

He will be based in Aliso Viejo, CA.

Grant joins Bausch + Lomb from Allergan, a company he joined in 2006 as corporate vice president and president of Allergan Medical. Before joining Allergan, Grant was acting chairman, president, and CEO of Biolase Technology, a cosmetic dentistry company, where he led a turnaround effort. He had joined Biolase in 2003 as chief operating officer and also served the organization as chief financial officer.

From 1997 to 2003, Grant held management positions with Lumenis (formerly Coherent Medical Group), including that of executive vice president of its ophthalmic business unit, executive vice president of its surgical business unit, vice president of business development, and managing director of European operations. His career also has included expatriate management positions with Sulzer Medica AG and Telectronics Pty Ltd.

Grant succeeds J. Andy Corley, who has been president of Bausch + Lomb surgical business since 2008. He will transition into a role as senior adviser to Bausch + Lomb CEO Brent Saunders and the company’s senior leadership team.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.